Detalhe da pesquisa
1.
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Lancet
; 403(10422): 147-159, 2024 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38008109
2.
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10382): 1079-1090, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868261
3.
Efficacy and safety of on-demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial.
Allergy
; 79(1): 93-103, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37597162
4.
Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial.
J Am Acad Dermatol
; 90(3): 485-493, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37852306
5.
Hidradenitis Suppurativa Is Associated with Severe Sexual Impairment.
Dermatology
; 240(2): 205-215, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190809
6.
The socio-economic burden of H1-antihistamine-refractory chronic spontaneous urticaria in Germany.
J Eur Acad Dermatol Venereol
; 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38733261
7.
Modelling of patient journey in chronic spontaneous urticaria: Increasing awareness and education by shorten patients' disease journey in Germany.
J Eur Acad Dermatol Venereol
; 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38441370
8.
Belastung durch gestörten Schlaf und dessen Verbesserung durch topische Behandlung bei Psoriasis und atopischer Dermatitis: Burden of impaired sleep and its improvement through topical treatment in psoriasis and atopic dermatitis.
J Dtsch Dermatol Ges
; 22(5): 655-664, 2024 May.
Artigo
em Alemão
| MEDLINE | ID: mdl-38730524
9.
Burden of impaired sleep and its improvement through topical treatment in psoriasis and atopic dermatitis.
J Dtsch Dermatol Ges
; 22(5): 655-663, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38634699
10.
A centre-based ambulatory care concept for hidradenitis suppurativa improves disease activity, disease burden and patient satisfaction: results from the randomized controlled EsmAiL trial.
Br J Dermatol
; 189(2): 170-179, 2023 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37132470
11.
Izokibep for the treatment of moderate-to-severe plaque psoriasis: a phase II, randomized, placebo-controlled, double-blind, dose-finding multicentre study including long-term treatment.
Br J Dermatol
; 189(4): 381-391, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37697683
12.
Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis.
Pediatr Allergy Immunol
; 34(7): e13982, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37492920
13.
Prospective Observational Evaluation of Fixed Combination Calcipotriol/Betamethasone Aerosol Foam (Enstilar®) in the Management of Psoriasis with Scalp Involvement in Everyday Clinical Practice (the CAPITIS Study).
Dermatology
; 239(2): 206-216, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36716728
14.
Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG-CU, a UCARE study.
J Eur Acad Dermatol Venereol
; 37(2): 356-364, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066999
15.
An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria.
J Allergy Clin Immunol
; 149(5): 1683-1690.e7, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34954198
16.
Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registries.
J Dtsch Dermatol Ges
; 21(10): 1170-1176, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37653583
17.
Ligelizumab for Chronic Spontaneous Urticaria.
N Engl J Med
; 381(14): 1321-1332, 2019 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31577874
18.
Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study.
Allergy
; 77(7): 2175-2184, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34773261
19.
A European survey of management approaches in chronic urticaria in children: EAACI pediatric urticaria taskforce.
Pediatr Allergy Immunol
; 33(1): e13674, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34601755
20.
LAight® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Results from Period A of RELIEVE, a Multicenter Randomized, Controlled Trial.
Dermatology
; 238(3): 476-486, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34535610